17 results
8-K
EX-10.1
ARVN
Arvinas Inc
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
, the synthesis, manufacturing, processing, formulating, packaging, labeling, holding, quality control testing and release of such Licensed Product … , but not formulations, packaging, labeling, analyzing or testing of such Licensed Product.
1.134 “Manufacturing-Specific Patents” means all Collaboration
8-K
EX-1.1
wl1g8n6z4u2y m9ua
18 Dec 20
Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock
6:30am
8-K
EX-1.1
cjy69sh7thqyoil
12 Nov 19
Arvinas, Inc. Announces Pricing of Public Offering of Common Stock
4:02pm
10-K
hj8zoy613eg6fpqj
26 Mar 19
Annual report
4:31pm
DRS/A
90yzovctnss9z3a
2 Aug 18
Draft registration statement (amended)
12:00am
DRS
EX-10.7
dmcsmhawd7hr7kq fv
22 Jun 18
Draft registration statement
12:00am
DRS
EX-10.6
4ewuw bqa6o1
22 Jun 18
Draft registration statement
12:00am
DRS
0fam20 jjh2rl6q
22 Jun 18
Draft registration statement
12:00am
- Prev
- 1
- Next